Evolving Strategies in Cardiac Amyloidosis: From Mechanistic Discoveries to Diagnostic and Therapeutic Advances

By sjmartinez • November 18, 2024

Stein-Merlob AF, Swier R, Vucicevic D. Evolving Strategies in Cardiac Amyloidosis: From Mechanistic Discoveries to Diagnostic and Therapeutic Advances. Cardiol Clin. 2025 Feb;43(1):93-110. doi: 10.1016/j.ccl.2024.09.006. Epub 2024 Oct 22. PMID: 39551565.

Tags: AL, Amyloid cardiomyopathy, amyloidosis, Cardiology/Epi, Fibril, General Internal Medicine, Misfolded, Publications, Resident, Transthyretin, TTR

When Is Enough Enough? Additional Evidence of the Power of Zero

Budoff MJ. When Is Enough Enough? Additional Evidence of the Power of Zero. Circ Cardiovasc Imaging. 2024 Dec 20:e017714. doi: 10.1161/CIRCIMAGING.124.017714. Epub ahead of print.[...]

“Anti-inflammatory Therapies in Atherosclerosis – Where are we going?”

Punnanithinont N, Kambalapalli S, Iskander B, Ichikawa K, Krishnan S, Lakshmanan S, Roy SK, Budoff M. "Anti-inflammatory Therapies in Atherosclerosis - Where are we going?".[...]

First comparison between artificial intelligence-guided coronary computed tomography angiography versus single-photon emission computed tomography testing for ischemia in clinical practice

Cho GW, Sayed S, D'Costa Z, Karlsberg DW, Karlsberg RP. First comparison between artificial intelligence-guided coronary computed tomography angiography versus single-photon emission computed tomography testing[...]